A Trusted Research Environment (TRE) is more than a secure IT platform. To qualify, a platform needs safeguards in six areas that work together to ensure researchers can safely analyse sensitive personal data. A new whitepaper defines these technical and organizational requirements, based on over eight years’ experience in running BioMedIT – Switzerland’s only operational national TRE network. It also shows the requirements align with an emerging international consensus on what TREs should provide. The whitepaper is published by the Swiss Personalized Health Network (SPHN) and BioMedIT nodes at ETH Zurich, the University of Basel and the University of Lausanne.
A practical TRE definition drawn from Swiss experience
Sensitive personal data can only be used for research inside environments that protect data privacy and comply with legal and ethical regulations. Trusted Research Environments – computing platforms that combine technology, processes, data and people – have emerged as the accepted solution for this. Providers, funders and users still face a practical question however: what must a platform deliver, technically and organizationally, to qualify as a TRE?
A new whitepaper answers this, based on national experience in running BioMedIT (see box). Its authors stress that while secure infrastructure is an essential foundation, no single technology makes a platform trustworthy. Instead, safeguards in six areas must work together to ensure sensitive data are used in a safe, secure and compliant manner.
The requirements align strongly with four international TRE frameworks (see below) developed since BioMedIT was established, including for the European Health Data Space. This confirms that Switzerland’s national TRE model is well positioned within the European landscape. The analysis also supports BioMedIT’s role as the proven national platform for research with sensitive health data, supporting major data providers and multi-centric research projects.
The whitepaper is published by SPHN (coordinated by the Swiss Academy of Medical Sciences and SIB) and BioMedIT nodes at ETH Zurich, the University of Basel and the University of Lausanne. It follows an earlier whitepaper outlining the need for versatile TREs to support research.
BioMedIT: a pioneering TRE network
BioMedIT provides a secure, high-performance IT infrastructure for research using sensitive human health data. In operation since 2018, the network federates three TRE nodes at ETH Zurich, the University of Basel and the University of Lausanne with a central team at SPHN, which is operated by SIB and SAMS. It currently connects 47 data-providing institutions, including all Swiss university hospitals, and can be used for mono- and multi-site, individual, and collaborative research projects. By August 2026 it had hosted more than 120 national and international projects and had 1,400 registered users.
BioMedIT is an integral part of the federally mandated SPHN. It is co-funded by the Swiss State Secretariat for Education, Research and Innovation (SERI) and the participating institutions.
Six technical and organizational safeguards qualify a platform as a TRE
The whitepaper groups TRE requirements in six areas spanning technical and organizational controls. These apply to standalone and federated TREs and set no specific technologies, so different platforms can meet them in different ways.
BioMedIT: a pioneering TRE network
BioMedIT provides a secure, high-performance IT infrastructure for research using sensitive human health data. In operation since 2018, the network federates three TRE nodes at ETH Zurich, the University of Basel and the University of Lausanne with a central team at SPHN, which is operated by SIB and SAMS. It currently connects 47 data-providing institutions, including all Swiss university hospitals, and can be used for mono- and multi-site, individual, and collaborative research projects. By August 2026 it had hosted more than 120 national and international projects and had 1,400 registered users.
BioMedIT is an integral part of the federally mandated SPHN. It is co-funded by the Swiss State Secretariat for Education, Research and Innovation (SERI) and the participating institutions.
Secure infrastructure: infrastructure kept separate from other computing services, which enables researchers to work with sensitive data in a controlled, compliant way; adapts to new data types, tools and computing demands; and keeps sensitive data in the country or legal region where the TRE operates.
Security management: a planned security architecture and an information security policy covering the full lifecycle of protection, from identifying assets to responding to and recovering from incidents.
Harmonized service offering: a consistent experience for researchers, with common tools for identity management and secure data transfer, controlled remote access and transparent pricing.
Service management: services planned, delivered and assessed with established IT service management processes and service level agreements.
Support and awareness: mandatory security and privacy training for the people who use and run the TRE, risk assessments, standard operating procedures, documentation and accessible helpdesks.
Ethical and legal compliance and support: support for projects to secure a sound legal basis and ethical approval before onboarding, de-identification of data as far as practical, and use of model legal agreements.
BioMedIT aligns closely with emerging international TRE consensus
BioMedIT was built for Swiss personalized health research before any clear TRE standards existed. To assess its broader relevance, the authors compared the requirements with four leading frameworks developed since:
- a community-led UK TRE specification (Standard Architecture for Trusted Research Environments; SATRE);
- a blueprint for a UK-wide TRE network (Data and Analytics Research Environments UK; DARE UK);
- a blueprint for a Europe-wide TRE network (European Open Science Cloud project EOSC-ENTRUST);
- specifications for secure processing environments under the European Health Data Space, the EU regulation governing the use of health data (from the TEHDAS2 project).
Despite being written by different communities in different legal contexts, all four align strongly with the whitepaper’s requirements. The authors see this convergence as evidence of a shared international view on how to process sensitive personal data responsibly.